If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVCS.L Regulatory News (PVCS)

  • There is currently no data for PVCS

Issue of Equity

5 Jul 2007 16:35

PV Crystalox Solar PLC05 July 2007 05 July 2007 Not for publication, distribution or release in, or into, directly orindirectly, the United States, Canada, Australia, Japan or to US persons. The securities under the Offering are not being registered under the UnitedState Securities Act of 1933, as amended and may not be offered or sold in theUnited States or to US persons (as such terms are defined in Regulation S undersuch Act) absent registration or an exemption from registration. PV Crystalox Solar Plc ("PV Crystalox Solar" or the "Company") Announcement of Exercise of Over-Allotment Option PV Crystalox Solar Plc announces that, in connection with its initial publicoffering of ordinary shares, (the "Offering"), JPMorgan Cazenove Limited, asstabilising manager and on behalf of the underwriters of the Offering, has todaygiven notice to exercise in full the over-allotment option in respect of19,089,995 existing ordinary shares at the offer price of 130 pence per ordinaryshare. None of the proceeds arising from the exercise of the over-allotmentoption will be payable to the Company. Following the exercise of the over-allotment option, 188,081,886 ordinary shareswill be held in public hands, representing a free float of approximately 45.1per cent of the issued share capital of the Company. For further information, please contact: PV Crystalox Solar Plc Tel: +44 (0)1235 770 044Iain Dorrity, Chief Executive OfficerPeter Finnegan, Chief Financial OfficerDr Hubert Aulich, Executive Director, German Operations Tel: +49 (0)361 600 8512 JPMorgan Cazenove Limited: Tel: +44 (0)20 7588 2828Nick GarrettAlex Yule-Smith Gavin Anderson & Company Tel: +44 (0)20 7554 1400Kate HillRobert Speed This announcement and the information contained herein is not for publication,distribution or release in, or into, directly or indirectly, the United States,Canada, Australia, Japan or to US persons. The information contained herein doesnot constitute an offer of securities for sale in any jurisdiction, including inthe United States, Australia, Canada, Japan. The Offering and the distributionof this announcement and other information in connection with the Offering incertain jurisdictions may be restricted by law and persons into whose possessionthis announcement comes should inform themselves about, and observe, any suchrestrictions. Any failure to comply with these restrictions may constitute aviolation of the securities laws of any such jurisdiction. JPMorgan Cazenove Limited, which is authorised and regulated in the UnitedKingdom by the Financial Services Authority, is acting for PV Crystalox Solarand no one else in connection with the Offering referred to in this and will notbe responsible to any other person for providing the protections afforded totheir respective clients or for providing advice in relation to the Offering. This announcement does not constitute a recommendation concerning the Offeringand any subscription for or purchase of shares in PV Crystalox Solar should onlybe made on the basis of information contained in the prospectus dated 6 June2007 and any supplements thereto. The value of securities can go down as well asup. Past performance is not a guide to future performance. Potential investorsshould consult a professional adviser as to the suitability of any Offering forthe individual concerned. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Oct 201612:18 pmRNSHolding(s) in Company
28th Sep 201610:48 amRNSTermination of polysilicon L/T purchase contract
31st Aug 20164:44 pmRNSHolding(s) in Company
25th Aug 20167:00 amRNSHalf-year Report
5th Jul 20164:40 pmRNSSecond Price Monitoring Extn
5th Jul 20164:35 pmRNSPrice Monitoring Extension
1st Jul 201612:31 pmRNSHolding(s) in Company
21st Jun 201611:54 amRNSUpdate on arbitration
20th May 20169:57 amRNSAGM Results
20th May 20169:54 amRNSAGM Statement
18th May 201611:41 amRNSDirector/PDMR Shareholding
18th May 201611:37 amRNSDirector/PDMR Shareholding
18th May 201611:35 amRNSDirector/PDMR Shareholding
20th Apr 20164:35 pmRNSPrice Monitoring Extension
17th Mar 20167:00 amRNSPreliminary Results
26th Feb 20164:00 pmRNSHome Member State Notification
17th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20167:00 amRNSTrading Statement
29th Dec 20154:40 pmRNSSecond Price Monitoring Extn
29th Dec 20154:35 pmRNSPrice Monitoring Extension
23rd Dec 20154:40 pmRNSSecond Price Monitoring Extn
23rd Dec 20154:35 pmRNSPrice Monitoring Extension
17th Dec 20154:40 pmRNSSecond Price Monitoring Extn
17th Dec 20154:35 pmRNSPrice Monitoring Extension
4th Dec 20154:40 pmRNSSecond Price Monitoring Extn
4th Dec 20154:35 pmRNSPrice Monitoring Extension
4th Dec 201510:24 amRNSHolding(s) in Company
24th Sep 20153:19 pmRNSHolding(s) in Company
27th Aug 20157:01 amRNSInterim Results
14th Aug 20152:42 pmRNSHolding(s) in Company
26th May 20153:05 pmRNSResult of AGM
21st May 20154:45 pmRNSAGM Statement
2nd Apr 201510:53 amRNSHolding(s) in Company
27th Mar 20152:28 pmRNSHolding(s) in Company
24th Mar 20153:30 pmRNSHolding(s) in Company
19th Mar 20157:00 amRNSPreliminary Results
18th Feb 201512:46 pmRNSHolding(s) in Company
5th Feb 20153:14 pmRNSHolding(s) in Company
2nd Feb 20153:56 pmRNSHolding(s) in Company
30th Jan 20154:01 pmRNSDirector Declaration
30th Jan 20153:59 pmRNSHolding(s) in Company
21st Jan 201510:29 amRNSHolding(s) in Company
15th Jan 20154:35 pmRNSPrice Monitoring Extension
10th Dec 20144:40 pmRNSSecond Price Monitoring Extn
10th Dec 20144:35 pmRNSPrice Monitoring Extension
19th Nov 20147:00 amRNSInterim Management Statement
10th Sep 20144:35 pmRNSPrice Monitoring Extension
3rd Sep 20144:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20144:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.